Featured Research

from universities, journals, and other organizations

Laboratory Study Shows Measles Vaccine May Offer Novel Approach For Treating Lymphoma

Date:
June 12, 2001
Source:
Mayo Clinic
Summary:
The virus strain used worldwide for more than 30 years to produce the measles vaccine may be effective for another purpose — fighting lymphoma, a group of cancers that originate in the lymphatic system.

ROCHESTER, MINN. — The virus strain used worldwide for more than 30 years to produce the measles vaccine may be effective for another purpose — fighting lymphoma, a group of cancers that originate in the lymphatic system.

Scientists with Mayo Clinic’s molecular medicine program have found that the measles vaccine virus caused remission of lymphoma in mice injected with human cells containing the cancer. The findings from the study are published in the June 15 issue of Blood, Journal of the American Society of Hematology.

This laboratory study is thought to be the first research conducted by any medical research institution to demonstrate the destructive effects of the measles vaccine virus on lymphoma cells. It is one of several research studies underway at Mayo Clinic to investigate the effects of the measles vaccine virus on cancer.

Adele Fielding, M.D., Ph.D., lead researcher on the newly-published Mayo Clinic study, describes the findings as an early step in potentially developing the measles vaccine virus into a treatment for patients with advanced lymphomas.

"Our research involved the use of derivatives of the Edmonston-B strain of the measles vaccine to study its effects on both aggressive and slow-growing B-cell lymphoma," says Dr. Fielding.

"We found that injecting the vaccine strain of the virus into the tumor caused remission of the large, established human B-cell lymphoma in laboratory mice with the cancer," she said. "Intravenous administration of the vaccine strain also resulted in considerable slowing of tumor progression in the mice."

"Our study therefore proves the principle that the measles vaccine virus destroys lymphoma cells," says Dr. Fielding.

A pilot study is now underway at Mayo Clinic to test the use of the live measles vaccine virus in patients diagnosed with lymphoma. "If our laboratory findings translate to patients, then our research may lead to another treatment for patients who have failed current therapies for lymphoma and have exhausted their options for fighting the disease," says Dr. Fielding.

The two main types of lymphoma include Hodgkin’s disease and non-Hodgkin’s lymphoma, each having its own patterns of growth, spread and response to treatment. This year, an estimated 63,600 Americans will be diagnosed with lymphoma and about 27,600 patients will die of the cancer. Unlike several other cancers that appear to be declining in incidence rates, lymphoma is on the increase nationally, according to the National Cancer Institute.

Chemotherapy alone or in combination with radiation therapy is the standard treatment for lymphoma. High-dose chemotherapy with bone marrow transplantation is the treatment used for patients who relapse after standard treatment. If proved effective, the treatment derived from the measles vaccine virus could become another treatment option for patients with relapsed lymphoma.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Laboratory Study Shows Measles Vaccine May Offer Novel Approach For Treating Lymphoma." ScienceDaily. ScienceDaily, 12 June 2001. <www.sciencedaily.com/releases/2001/06/010611072804.htm>.
Mayo Clinic. (2001, June 12). Laboratory Study Shows Measles Vaccine May Offer Novel Approach For Treating Lymphoma. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2001/06/010611072804.htm
Mayo Clinic. "Laboratory Study Shows Measles Vaccine May Offer Novel Approach For Treating Lymphoma." ScienceDaily. www.sciencedaily.com/releases/2001/06/010611072804.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins